Moore Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,000
Closed -$276K 754
2021
Q4
$276K Sell
10,000
-10,000
-50% -$268K 0.01% 511
2021
Q3
$557K Sell
20,000
-99,412
-83% -$2.82M 0.01% 536
2021
Q2
$3.5M Buy
+119,412
New +$3.62M 0.05% 358
2015
Q2
Sell
-30,063
Closed -$5.97M 421
2015
Q1
$5.97M Buy
30,063
+15,777
+110% +$2.8M 0.13% 150
2014
Q4
$2.04M Sell
14,286
-16,258
-53% -$2.19M 0.06% 220
2014
Q3
$4.01M Sell
30,544
-96,878
-76% -$11.5M 0.09% 217
2014
Q2
$16.1M Buy
127,422
+119,878
+1,589% +$15.3M 0.39% 67
2014
Q1
$995K Buy
7,544
+2,838
+60% +$388K 0.02% 312
2013
Q4
$552K Sell
4,706
-174
-4% -$19.1K 0.01% 330
2013
Q3
$509K Buy
+4,880
New +$475K 0.01% 318

Other funds holding BHC

Moore Capital Management's BHC Position: Q1 2022 in Review

Moore Capital Management sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 10,000 shares — an estimated $276K sold.

Moore Capital Management first reported a position in BHC in Q3 2013 and held it in 10 quarters. The position peaked at $16.1M in Q2 2014. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • Moore Capital Management reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • Moore Capital Management sold 10,000 Bausch Health shares in Q1 2022, an estimated $276K.
  • Moore Capital Management first reported a position in Bausch Health in Q3 2013 and held it in 10 quarters.
  • Moore Capital Management's Bausch Health position peaked at $16.1M in Q2 2014.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Moore Capital Management's 13F filing for Q1 2022, filed 16 May 2022.